Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) mNo edit summary |
||
| Line 2,988: | Line 2,988: | ||
==WHO Central Nervous System Tumours (5th ed.) Content== | ==WHO Central Nervous System Tumours (5th ed.) Content== | ||
} | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| Line 2,998: | Line 3,000: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
| | |Astrocytoma, IDH-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,006: | Line 3,008: | ||
| | | | ||
|- | |- | ||
| | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,014: | Line 3,016: | ||
| | | | ||
|- | |- | ||
| | |Glioblastoma, IDH-wildtype||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,022: | Line 3,024: | ||
| | | | ||
|- | |- | ||
| | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,030: | Line 3,032: | ||
| | | | ||
|- | |- | ||
| | |Angiocentric glioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,038: | Line 3,040: | ||
| | | | ||
|- | |- | ||
| | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,046: | Line 3,048: | ||
| | | | ||
|- | |- | ||
| | |Diffuse low-grade glioma, MAPK pathway-altered||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,054: | Line 3,056: | ||
| | | | ||
|- | |- | ||
| | |Diffuse midline glioma, H3 K27-altered||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,062: | Line 3,064: | ||
| | | | ||
|- | |- | ||
| | |Diffuse hemispheric glioma, H3 G34-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,070: | Line 3,072: | ||
| | | | ||
|- | |- | ||
| | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,078: | Line 3,080: | ||
| | | | ||
|- | |- | ||
| | |Infant-type hemispheric glioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,086: | Line 3,088: | ||
| | | | ||
|- | |- | ||
| | |Pilocytic astrocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,094: | Line 3,096: | ||
| | | | ||
|- | |- | ||
| | |High-grade astrocytoma with piloid features||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,102: | Line 3,104: | ||
| | | | ||
|- | |- | ||
| | |Pleomorphic xanthoastrocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,110: | Line 3,112: | ||
| | | | ||
|- | |- | ||
| | |Subependymal giant cell astrocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,118: | Line 3,120: | ||
| | | | ||
|- | |- | ||
| | |Chordoid glioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,126: | Line 3,128: | ||
| | | | ||
|- | |- | ||
| | |Astroblastoma, MN1-altered||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,134: | Line 3,136: | ||
| | | | ||
|- | |- | ||
| | |Ganglioglioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,142: | Line 3,144: | ||
| | | | ||
|- | |- | ||
| | |Gangliocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,150: | Line 3,152: | ||
| | | | ||
|- | |- | ||
| | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,158: | Line 3,160: | ||
| | | | ||
|- | |- | ||
| | |Dysembryoplastic neuroepithelial tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,166: | Line 3,168: | ||
| | | | ||
|- | |- | ||
| | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,174: | Line 3,176: | ||
| | | | ||
|- | |- | ||
| | |Papillary glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,182: | Line 3,184: | ||
| | | | ||
|- | |- | ||
| | |Rosette-forming glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,190: | Line 3,192: | ||
| | | | ||
|- | |- | ||
| | |Myxoid glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,198: | Line 3,200: | ||
| | | | ||
|- | |- | ||
| | |Diffuse leptomeningeal glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,206: | Line 3,208: | ||
| | | | ||
|- | |- | ||
| | |Multinodular and vacuolating neuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,214: | Line 3,216: | ||
| | | | ||
|- | |- | ||
| | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,222: | Line 3,224: | ||
| | | | ||
|- | |- | ||
| | |Central neurocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,230: | Line 3,232: | ||
| | | | ||
|- | |- | ||
| | |Extraventricular neurocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,238: | Line 3,240: | ||
| | | | ||
|- | |- | ||
| | |Cerebellar liponeurocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,246: | Line 3,248: | ||
| | | | ||
|- | |- | ||
| | |Supratentorial ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,254: | Line 3,256: | ||
| | | | ||
|- | |- | ||
| | |Supratentorial ependymoma, ZFTA fusion-positive||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,262: | Line 3,264: | ||
| | | | ||
|- | |- | ||
| | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,270: | Line 3,272: | ||
| | | | ||
|- | |- | ||
| | |Posterior fossa ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,278: | Line 3,280: | ||
| | | | ||
|- | |- | ||
| | |Posterior fossa group A (PFA) ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,286: | Line 3,288: | ||
| | | | ||
|- | |- | ||
| | |Posterior fossa group B (PFB) ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,294: | Line 3,296: | ||
| | | | ||
|- | |- | ||
| | |Spinal ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,302: | Line 3,304: | ||
| | | | ||
|- | |- | ||
| | |Spinal ependymoma, MYCN-amplified||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,310: | Line 3,312: | ||
| | | | ||
|- | |- | ||
| | |Myxopapillary ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,318: | Line 3,320: | ||
| | | | ||
|- | |- | ||
| | |Subependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,326: | Line 3,328: | ||
| | | | ||
|- | |- | ||
| | |Choroid plexus papilloma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,334: | Line 3,336: | ||
| | | | ||
|- | |- | ||
| | |Atypical choroid plexus papilloma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,342: | Line 3,344: | ||
| | | | ||
|- | |- | ||
| | |Choroid plexus carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,350: | Line 3,352: | ||
| | | | ||
|- | |- | ||
| | |Medulloblastoma, WNT-activated||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,358: | Line 3,360: | ||
| | | | ||
|- | |- | ||
| | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,366: | Line 3,368: | ||
| | | | ||
|- | |- | ||
| | |Medulloblastoma, SHH-activated and TP53-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,374: | Line 3,376: | ||
| | | | ||
|- | |- | ||
| | |Medulloblastoma, non-WNT/non-SHH||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,382: | Line 3,384: | ||
| | | | ||
|- | |- | ||
| | |Medulloblastoma, histologically defined||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,390: | Line 3,392: | ||
| | | | ||
|- | |- | ||
| | |Atypical teratoid/rhabdoid tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,398: | Line 3,400: | ||
| | | | ||
|- | |- | ||
| | |Cribriform neuroepithelial tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,406: | Line 3,408: | ||
| | | | ||
|- | |- | ||
| | |Embryonal tumour with multilayered rosettes||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,414: | Line 3,416: | ||
| | | | ||
|- | |- | ||
| | |CNS neuroblastoma, FOXR2-activated||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,422: | Line 3,424: | ||
| | | | ||
|- | |- | ||
| | |CNS tumour with BCOR internal tandem duplication||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,430: | Line 3,432: | ||
| | | | ||
|- | |- | ||
| | |CNS embryonal tumour NEC/NOS||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,438: | Line 3,440: | ||
| | | | ||
|- | |- | ||
| | |Pineocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,446: | Line 3,448: | ||
| | | | ||
|- | |- | ||
| | |Pineal parenchymal tumour of intermediate differentiation||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,454: | Line 3,456: | ||
| | | | ||
|- | |- | ||
| | |Pineoblastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,462: | Line 3,464: | ||
| | | | ||
|- | |- | ||
| | |Papillary tumour of the pineal region||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,470: | Line 3,472: | ||
| | | | ||
|- | |- | ||
| | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,478: | Line 3,480: | ||
| | | | ||
|- | |- | ||
| | |Schwannoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,486: | Line 3,488: | ||
| | | | ||
|- | |- | ||
| | |Neurofibroma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,494: | Line 3,496: | ||
| | | | ||
|- | |- | ||
| | |Perineurioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,502: | Line 3,504: | ||
| | | | ||
|- | |- | ||
| | |Hybrid nerve sheath tumours||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,510: | Line 3,512: | ||
| | | | ||
|- | |- | ||
| | |Malignant melanotic nerve sheath tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,518: | Line 3,520: | ||
| | | | ||
|- | |- | ||
| | |Malignant peripheral nerve sheath tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,526: | Line 3,528: | ||
| | | | ||
|- | |- | ||
| | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,534: | Line 3,536: | ||
| | | | ||
|- | |- | ||
| | |Meningioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,542: | Line 3,544: | ||
| | | | ||
|- | |- | ||
| | |Solitary fibrous tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,550: | Line 3,552: | ||
| | | | ||
|- | |- | ||
| | |Haemangiomas and vascular malformations||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,558: | Line 3,560: | ||
| | | | ||
|- | |- | ||
| | |Haemangioblastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,566: | Line 3,568: | ||
| | | | ||
|- | |- | ||
| | |Rhabdomyosarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,574: | Line 3,576: | ||
| | | | ||
|- | |- | ||
| | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,582: | Line 3,584: | ||
| | | | ||
|- | |- | ||
| | |CIC-rearranged sarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,590: | Line 3,592: | ||
| | | | ||
|- | |- | ||
| | |Primary intracranial sarcoma, DICER1-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,598: | Line 3,600: | ||
| | | | ||
|- | |- | ||
| | |Ewing sarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,606: | Line 3,608: | ||
| | | | ||
|- | |- | ||
| | |Mesenchymal chondrosarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,614: | Line 3,616: | ||
| | | | ||
|- | |- | ||
| | |Chondrosarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,622: | Line 3,624: | ||
| | | | ||
|- | |- | ||
| | |Chordoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,630: | Line 3,632: | ||
| | | | ||
|- | |- | ||
| | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,638: | Line 3,640: | ||
| | | | ||
|- | |- | ||
| | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,646: | Line 3,648: | ||
| | | | ||
|- | |- | ||
| | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,654: | Line 3,656: | ||
| | | | ||
|- | |- | ||
| | |Immunodeficiency-associated CNS lymphomas||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,662: | Line 3,664: | ||
| | | | ||
|- | |- | ||
| | |Lymphomatoid granulomatosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,670: | Line 3,672: | ||
| | | | ||
|- | |- | ||
| | |Intravascular large B-cell lymphoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,678: | Line 3,680: | ||
| | | | ||
|- | |- | ||
| | |MALT lymphoma of the dura||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,686: | Line 3,688: | ||
| | | | ||
|- | |- | ||
| | |Other low-grade B-cell lymphomas of the CNS||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,694: | Line 3,696: | ||
| | | | ||
|- | |- | ||
| | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,702: | Line 3,704: | ||
| | | | ||
|- | |- | ||
| | |T-cell and NK/T-cell lymphomas||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,710: | Line 3,712: | ||
| | | | ||
|- | |- | ||
| | |Erdheim-Chester disease||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,718: | Line 3,720: | ||
| | | | ||
|- | |- | ||
| | |Rosai-Dorfman disease||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,726: | Line 3,728: | ||
| | | | ||
|- | |- | ||
| | |Juvenile xanthogranuloma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,734: | Line 3,736: | ||
| | | | ||
|- | |- | ||
| | |Langerhans cell histiocytosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,742: | Line 3,744: | ||
| | | | ||
|- | |- | ||
| | |Histiocytic sarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,750: | Line 3,752: | ||
| | | | ||
|- | |- | ||
| | |Germ cell tumours of the CNS||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,758: | Line 3,760: | ||
| | | | ||
|- | |- | ||
| | |Adamantinomatous craniopharyngioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,766: | Line 3,768: | ||
| | | | ||
|- | |- | ||
| | |Papillary craniopharyngioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,774: | Line 3,776: | ||
| | | | ||
|- | |- | ||
| | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,782: | Line 3,784: | ||
| | | | ||
|- | |- | ||
| | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,790: | Line 3,792: | ||
| | | | ||
|- | |- | ||
| | |Pituitary blastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,798: | Line 3,800: | ||
| | | | ||
|- | |- | ||
| | |Metastases to the brain and spinal cord parenchyma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,806: | Line 3,808: | ||
| | | | ||
|- | |- | ||
| | |Metastases to the meninges||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,814: | Line 3,816: | ||
| | | | ||
|- | |- | ||
| | |Neurofibromatosis type 1||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,822: | Line 3,824: | ||
| | | | ||
|- | |- | ||
| | |Neurofibromatosis type 2||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,830: | Line 3,832: | ||
| | | | ||
|- | |- | ||
| | |Schwannomatosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,838: | Line 3,840: | ||
| | | | ||
|- | |- | ||
| | |Von Hippel-Lindau syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,846: | Line 3,848: | ||
| | | | ||
|- | |- | ||
| | |Tuberous sclerosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,854: | Line 3,856: | ||
| | | | ||
|- | |- | ||
| | |Li-Fraumeni syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,862: | Line 3,864: | ||
| | | | ||
|- | |- | ||
| | |Cowden syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,870: | Line 3,872: | ||
| | | | ||
|- | |- | ||
| | |Constitutional mismatch repair deficiency syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,878: | Line 3,880: | ||
| | | | ||
|- | |- | ||
| | |Familial adenomatous polyposis 1||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,886: | Line 3,888: | ||
| | | | ||
|- | |- | ||
| | |Naevoid basal cell carcinoma syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,894: | Line 3,896: | ||
| | | | ||
|- | |- | ||
| | |Rhabdoid tumour predisposition syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,902: | Line 3,904: | ||
| | | | ||
|- | |- | ||
| | |Carney complex||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,910: | Line 3,912: | ||
| | | | ||
|- | |- | ||
| | |DICER1 syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,918: | Line 3,920: | ||
| | | | ||
|- | |- | ||
| | |Familial paraganglioma syndromes||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,926: | Line 3,928: | ||
| | | | ||
|- | |- | ||
| | |Melanoma-astrocytoma syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,934: | Line 3,936: | ||
| | | | ||
|- | |- | ||
| | |Familial retinoblastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,942: | Line 3,944: | ||
| | | | ||
|- | |- | ||
| | |BAP1 tumour predisposition syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,950: | Line 3,952: | ||
| | | | ||
|- | |- | ||
| | |Fanconi anaemia||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,958: | Line 3,960: | ||
| | | | ||
|- | |- | ||
| | |ELP1-medulloblastoma syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,966: | Line 3,968: | ||
| | | | ||
|- | |- | ||
} | |} | ||